Company No: 12187224 (England and Wales)

Contents

• Balance Sheet
• Notes to the Financial Statements

		2025		2024
		£		£
Fixed assets		4,664		4,473
Current assets		19,430		16,580
Creditors: amounts falling due within one year		( 4,842)		( 7,697)
Net current assets		14,588		8,883
Total assets less current liabilities		19,252		13,356
Accruals and deferred income		( 1,512)		( 1,453)
Net assets		17,740		11,903
Capital and reserves		17,740		11,903

For the financial year ending 30 September 2025 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

• The members have not required the Company to obtain an audit of its financial statements for the financial year in accordance with section 476;
• The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements;
• These financial statements have been prepared in accordance with the micro-entity provisions of the Companies Act 2006 and FRS 105 The Financial Reporting Standard applicable to the Micro-entities Regime;
• These financial statements have been delivered in accordance with the small companies regime and a copy of the Profit and Loss Account has not been delivered.

The financial statements of Bristol Paediatric Urology Limited (registered number: 12187224) were approved and authorised for issue by the Board of Directors on 02 May 2026 and were signed on its behalf by:

Mohamed Sameh Ahmed Elsayed Shalaby Director

1. Company information

The Company is a private company limited by shares and is incorporated in the United Kingdom and registered in England and Wales (Company no. 12187224). The address of its registered office is 5th Floor 25 King Street, Bristol, BS1 4PB, United Kingdom.

2. Employees

	2025		2024
	Number		Number
Monthly average number of persons employed by the Company during the financial year, including directors	2		2

3. Directors’ benefits: advances, credit and guarantees

Advances

The Directors loan account is repayable on demand and interest is charged on overdrawn balances at the official HMRC rates.

At 1 October 2024, the balance owed to the directors was £312. During the year, £5,779 was advanced to the directors, and £312 was repaid by the directors. At 30 September 2025, the balance owed by the directors was £5,155.

At 1 October 2023, the balance owed to the directors was £922. During the year, £1,605 was advanced to the directors, and £995 was repaid by the directors. At 30 September 2024, the balance owed by the directors was £312.